Dori A, Guglieri M, Scutifero M, Passamano L, Trabacca L, Politano L. Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up. Acta Myol [Internet]. 2022 Mar. 31 [cited 2024 Dec. 4];41(1). Available from: https://www.actamyologica.it/article/view/435